Has Mark Goldstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,669 in general payments to Mark Goldstein, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Goldstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Goldstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Goldstein, MD

Emergency Medicine · Germantown, MDNPI 1760656631

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.8% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,669in general payments, 2019–2025

Across 45 payments — averaging $37.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$194
AstraZeneca$190
Rigel Pharmaceuticals, Inc.$157
Inari Medical, Inc.$151
Medical Device Business Services, Inc.$137
Penumbra, Inc.$119
plus $721 from 14 others

What the payments were for

Food & beverage$1,53292%
Education$1378%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	4	$194
AstraZeneca	4	$190
Rigel Pharmaceuticals, Inc.	2	$157
Inari Medical, Inc.	4	$151
Medical Device Business Services, Inc.	1	$137
Penumbra, Inc.	1	$119
Johnson & Johnson(2 entities)	4	$118
Bristol Myers Squibb	4	$118
GSK	5	$114
E.r. Squibb & Sons, L.L.C.	3	$79
Daiichi Sankyo Inc.	2	$52
Pfizer	2	$50
Bioxcel Therapeutics, Inc.	2	$42
Array Biopharma Inc	1	$29
Pharmacosmos Therapeutics Inc.	1	$27
Kyowa Kirin, Inc.	1	$23
Novartis	1	$22
Myriad Genetic Laboratories, Inc.	1	$18
Biomerieux Inc	1	$15
Neos Therapeutics, LP	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,669 in reported general payments places this provider in the 95th percentile of 925 emergency medicine providers in Maryland.

See all emergency medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$98,014

Medicare patients

550

Services billed

589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CefuroximeCefuroxime Axetil	11	$167
Ondansetron OdtOndansetron	15	$92
Cyclobenzaprine Hcl	14	$63
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$41
Gabapentin	12	$36
Prednisone	11	$21

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Germantown

Joshua HellerGermantown$1K
Leana WenBaltimore$2.2M
Matthew LevyBaltimore$135K
Puneet ChopraLaurel$98K
Ron ElfenbeinBaltimore$60K
Asa MargolisBaltimore$21K
Benjamin BarlowGaithersburg$19K
Paul Blake ObrienPrince Frederick$17K
David ReitmanBethesda$16K
Binoy MistryBaltimore$15K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →